Close Menu

NEW YORK (360Dx) — Digital pathology firm PathAI announced today that it has closed a $60 million Series B financing round.

The round was led by new investor General Atlantic with participation from existing investors including General Catalyst. In conjunction with the round, General Atlantic Managing Director Michelle Dipp will join PathAI's board.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.